Drug
Penicillamine clinical trials
- studies test it
- 4
- open now
- 1
- in phase 3
- 0
- first study started
- 1999
Keep track of what changes. Save the Penicillamine studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Studies by the year they started
4 studies that test it; most in 1999 (1)
| Year | Studies |
|---|---|
| 1999 | 1 |
| 2017 | 1 |
| 2019 | 1 |
| 2023 | 1 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 1
- Phase 2
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 0 · Other 4
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (1) · Nanfang Hospital, Southern Medical University (1) · Second Affiliated Hospital, School of Medicine, Zhejiang University (1) · Southeast Renal Research Institute (1)
Often tested with
Tested in the same studies.
Unithiol (1) · Succimer (1) · Gluconic acid (1) · Ascorbic Acid (1)
Studies
Open first, then newest update. How each study uses Penicillamine is read from its arms, and is right about nine times in ten.
Testing it · 4
- Safety and Superiority of Penicillamine in Radiosensitization of Recurrent Head and Neck CancerRecruitingPhase 2Nanfang Hospital, Southern Medical UniversityNCT06103617Written as Penicillamine
- The Individual Therapy for Patients With Wilson's DiseaseStatus unknownEarly Phase 1Second Affiliated Hospital, School of Medicine, Zhejiang UniversityNCT03957720Written as Penicillamine
- Delivery of Inhibitors of Lysyl Oxidase (LysoLox) on Serial Angioplasty and Time to RestenosisStatus unknownPhase 2Southeast Renal Research InstituteNCT03106948Written as Cuprimine Oral Product
- Penicillamine, Low Copper Diet, and Radiation Therapy in Treating Patients With GlioblastomaCompletedPhase 2Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsNCT00003751Written as penicillamine
Given in every arm · 1 — Penicillamine is usual care beside what is tested
As the comparator · 2 — what is tested is compared with Penicillamine
- Trientine Tetrahydrochloride Administered Once a Day for the First Line Treatment of Wilson's Disease Patients.RecruitingPhase 3OrphalanNCT07465718Written as D-Penicillamine
- Trientine Tetrahydrochloride (TETA 4HCL) for the Treatment of Wilson's DiseaseCompletedPhase 3OrphalanNCT03539952Written as Penicillamine (D1-W12)
Codes
What other systems call Penicillamine · ClinicalTrials.gg INT007964
- MeSH (NLM) D010396PenicillamineConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) GNN1DV99GXPENICILLAMINEConfirmed FDA, NLM, Wikidata
- RxNorm 7975Confirmed FDA, Wikidata
- Wikidata Q421239D-penicillamineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C729PenicillamineConfirmed FDA, Wikidata
- DrugBank DB00859One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D010396 | Penicillamine | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | GNN1DV99GX | PENICILLAMINE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 7975 | — | Confirmed FDA, Wikidata |
| Wikidata | Q421239 | D-penicillamine | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C729 | Penicillamine | Confirmed FDA, Wikidata |
| DrugBank | DB00859 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.